HESTER BIOSCIENCES
Back to Cashflow Statement
|
HESTER BIOSCIENCES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹64 Cr | ₹65 Cr | ₹48 Cr | ₹24 Cr | ₹8.71 Cr |
What is the latest Cash Flow from Operating Activities ratio of HESTER BIOSCIENCES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹64 Cr |
| Mar2025 | ₹65 Cr |
| Mar2024 | ₹48 Cr |
| Mar2023 | ₹24 Cr |
| Mar2022 | ₹8.71 Cr |
How is Cash Flow from Operating Activities of HESTER BIOSCIENCES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹64 Cr | -0.57 | |
| Mar2025 | ₹65 Cr | 33.89 | |
| Mar2024 | ₹48 Cr | 104.20 | |
| Mar2023 | ₹24 Cr | 170.84 | |
| Mar2022 | ₹8.71 Cr | - | |
Compare Cash Flow from Operating Activities of peers of HESTER BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HESTER BIOSCIENCES | ₹1,877.5 Cr | 0.7% | 12.5% | 16.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
HESTER BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HESTER BIOSCIENCES | 0.7% |
12.5% |
16.9% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses